Skip to content

A Study to Asses Wellness Using a Brain Sensing Device on Physicians

A Feasibility Study Evaluating Mindfulness-Based Intervention Assessing A Wearable Wellness Brain Sensing Device (Muse-S) in Practicing Physicians

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04743973
Enrollment
40
Registered
2021-02-08
Start date
2021-08-15
Completion date
2024-09-01
Last updated
2024-12-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Quality of Life, Sleep, Stress, Emotional

Keywords

mindfulness, Wellness

Brief summary

A study to asses the feasibility of physicians using a wearable brain sensing wellness device during a time of increased work load, patient volume and stressors to assess the association between duration of active state and calm state as measured by the wearable brain sensing wellness device, and quality of life (QOL), subjective stress, sleep and resilience.

Detailed description

Participants will be instructed on how to use a brain sensing device and corresponding digital application to engage in structured digital mindfulness practices daily for 3 months. Subjects will be requested to use the device and practice daily, but the amount of time and frequency daily will be to their choosing. Subjects will also complete questionnaires and cognitive based testing throughout participation.

Interventions

Brain sensing headband that measures brain activity by detecting electrical impulses created by the brain.

Sponsors

InteraXon, Inc.
CollaboratorINDUSTRY
Cambridge Brain Sciences
CollaboratorINDUSTRY
Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* 18 years of age or older at time of consent * Practicing Physicians at Mayo Clinic * Not pregnant by subject self-report at time of consent * Have the ability to provide informed consent * Have the ability to complete all aspects of this trial * Have access to a smart phone or tablet device * Have no contraindicating comorbid health condition which would interfere with the proper use of the Muse-S™ system, as determined by the clinical investigators

Exclusion criteria

* Used an investigational drug within the past 30 days * Currently (within the past 3 weeks) been practicing mindfulness training on a weekly/regular basis * Currently (within 3 weeks) been enrolled in another clinical or research program (e.g. CAM) which intervenes on the patients' QOL, or stress * An unstable medical or mental health condition as determined by the physician investigator

Design outcomes

Primary

MeasureTime frameDescription
Frequency Adherence to Intervention3 monthsSummarizing frequency subjects use intervention during active study participation (during 3 month study period)
Duration Adherence to Intervention3 monthsSummarizing duration of time subjects use intervention during active study participation (during 3 month time period)

Secondary

MeasureTime frameDescription
Perceived Stress Scale (PSS) Score Difference90 daysThe Perceived Stress Scale (PSS) is a 10-item 5-point Likert scale that measures global life stress by assessing the degree (Never, almost never, sometimes, often and very often) to which experiences are appraised as uncontrollable or unpredictable. Scores can range from 0 to 40, with higher scores indicating greater perceived stress. The score difference is the average change from Day 90 to Baseline.
Resilience Score Difference90 daysResilience was measured using the Connor-Davison Resilience Scale 10 (CD-RS10). This is a 10-item, 5-point likert scale, validated, scoring system. Scores can range from 0 to 40, with higher scores indicating higher resilience. The CD-RS10 is a reliable means of assessing resilience and most often used in medical and/or disaster studies. Difference from Day 90 to baseline for the resilience score
LASA Score Difference90 daysQuality of Life was measured using the validated Linear Analogue Self-Assessment (LASA) scale. This measure is a 6-item, 11-point likert scale, validated scoring system that measure of quality of life (QOL), in which QOL is conceptualized as a multidimensional construct with five domains (physical, functional, emotional, spiritual, and social). In this measure, each domain can score 0 as the worst possible and 10 being the best possible. The total score for QoL could range from 0 to 60 with higher score indicating greater QoL. Change from Day 90 to Baseline for the LASA score

Countries

United States

Participant flow

Recruitment details

Participants who were patients in the long COVID-19 clinic were invited to participate if they were found to be eligible for the study.

Participants by arm

ArmCount
Muse-S Group
Participants used Muse-S for the study period (up to 3 months).
40
Total40

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyWithdrawal by Subject5

Baseline characteristics

CharacteristicMuse-S Group
Age, Continuous41.3 years
STANDARD_DEVIATION 11
Ethnicity (NIH/OMB)
Hispanic or Latino
2 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
38 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
LASA baseline score39.2 units on a scale
STANDARD_DEVIATION 6.59
Perceived Stress Scale baseline score11.1 units on a scale
STANDARD_DEVIATION 3.94
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
2 Participants
Race (NIH/OMB)
Black or African American
1 Participants
Race (NIH/OMB)
More than one race
1 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants
Race (NIH/OMB)
White
35 Participants
Resilience baseline score27.4 units on a scale
STANDARD_DEVIATION 5.01
Sex: Female, Male
Female
34 Participants
Sex: Female, Male
Male
6 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 40
other
Total, other adverse events
1 / 40
serious
Total, serious adverse events
0 / 40

Outcome results

Primary

Duration Adherence to Intervention

Summarizing duration of time subjects use intervention during active study participation (during 3 month time period)

Time frame: 3 months

ArmMeasureValue (MEAN)Dispersion
Muse-S GroupDuration Adherence to Intervention5.9 minutesStandard Deviation 1.9
Primary

Frequency Adherence to Intervention

Summarizing frequency subjects use intervention during active study participation (during 3 month study period)

Time frame: 3 months

ArmMeasureValue (MEAN)Dispersion
Muse-S GroupFrequency Adherence to Intervention57.8 times usedStandard Deviation 30.6
Secondary

LASA Score Difference

Quality of Life was measured using the validated Linear Analogue Self-Assessment (LASA) scale. This measure is a 6-item, 11-point likert scale, validated scoring system that measure of quality of life (QOL), in which QOL is conceptualized as a multidimensional construct with five domains (physical, functional, emotional, spiritual, and social). In this measure, each domain can score 0 as the worst possible and 10 being the best possible. The total score for QoL could range from 0 to 60 with higher score indicating greater QoL. Change from Day 90 to Baseline for the LASA score

Time frame: 90 days

ArmMeasureValue (MEAN)Dispersion
Muse-S GroupLASA Score Difference2.7 units on a scaleStandard Deviation 6
Secondary

Perceived Stress Scale (PSS) Score Difference

The Perceived Stress Scale (PSS) is a 10-item 5-point Likert scale that measures global life stress by assessing the degree (Never, almost never, sometimes, often and very often) to which experiences are appraised as uncontrollable or unpredictable. Scores can range from 0 to 40, with higher scores indicating greater perceived stress. The score difference is the average change from Day 90 to Baseline.

Time frame: 90 days

ArmMeasureValue (MEAN)Dispersion
Muse-S GroupPerceived Stress Scale (PSS) Score Difference-2.1 units on a scaleStandard Deviation 3.81
Secondary

Resilience Score Difference

Resilience was measured using the Connor-Davison Resilience Scale 10 (CD-RS10). This is a 10-item, 5-point likert scale, validated, scoring system. Scores can range from 0 to 40, with higher scores indicating higher resilience. The CD-RS10 is a reliable means of assessing resilience and most often used in medical and/or disaster studies. Difference from Day 90 to baseline for the resilience score

Time frame: 90 days

ArmMeasureValue (MEAN)Dispersion
Muse-S GroupResilience Score Difference1.4 units on a scaleStandard Deviation 3.9

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026